Clinical trial reportAmerican journal of hematologyPublished
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort
12 of 39 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- American journal of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Graft vs Host Disease; Cyclophosphamide; Immunosuppressive Agents; HLA Antigens; Transplantation Conditioning; Hematopoietic Stem Cell Transplantation; Transplantation, Homologous; Prospective Studies; Adult; Aged; Middle Aged
- PubMed ID
- 42674730
- PubMed Central ID
- PMC13656881
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked